Results 151 to 160 of about 484,364 (380)

High‐Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis

Annals of Neurology, EarlyView.
Objective Spinal cord (SC) atrophy correlates with and predicts the underlying progressive biology in active and non‐active multiple sclerosis (MS), thereby providing a biomarker for clinical trials and patient management. Initiation of disease‐modifying therapy (DMT) may be followed by early pronounced central nervous system (CNS) volume loss due to ...
Simone Sacco, Nico Papinutto, Vinicius A. Schoeps, Shuiting Cheng, William A. Stern, Haojun Zhao, Antje Bischof, Eduardo Caverzasi, Manula Dombagahawatta, Jeremy Juwono, Amit Akula, Christian Cordano, Alexandra Beaudry‐Richard, Refujia Gomez, Meagan Harms, Adam Santaniello, Riley M. Bove, Jeffrey M. Gelfand, Douglas S. Goodin, Ari J. Green, Jorge R. Oksenberg, Emmanuelle Waubant, Michael R. Wilson, Scott S. Zamvil, Bruce A. C. Cree, Stephen L. Hauser, Roland G. Henry   +26 more
wiley   +1 more source

Placebos in the Treatment of Rheumatoid Arthritis and other Rheumatic Conditions

, 1957
Eugene F. Traut, E Passarelli
openalex   +1 more source

Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy

Annals of Neurology, EarlyView.
Objective Exenatide, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, has neuroprotective effects in preclinical models of multiple system atrophy (MSA). We investigated these effects in a proof‐of‐concept clinical trial. Methods In this single‐center, randomized, open label trial, participants with MSA were randomly assigned (1:1) to receive ...
Nirosen Vijiaratnam, Christine Girges, Martin Wiegand, Claudia Ismail, Alexandra Lameirinhas, Alison Yarnall, Cameron Kirk, Silvia Del‐Din, Lynn Rochester, Christopher Kobylecki, Gareth Ambler, Simon Skene, Henry Houlden, Viorica Chelban, Amanda Heslegrave, Wendy Phillips, Alan Whone, Niall Quinn, Christian Lambert, Charlotte Dore, Huw R. Morris, Mathew H. Horrocks, Ji Eun Lee, Judi O'Shaughnessy, Yazhou Li, Nigel H. Greig, Sonia Gandhi, Vincenzo Libri, Dilan Athauda, Tom Foltynie   +29 more
wiley   +1 more source

The Meaning of Patent Citations: Report on the NBER/Case-Western Reserve Survey of Patentees [PDF]

A survey of recent patentees was conducted to elicit their perceptions regarding the importance of their inventions, the extent of their communication with other inventors, and the relationship of both importance and communication to observed patent ...
Adam B. Jaffe, Manuel Trajtenberg, Michael S. Fogarty   +2 more
core  

RESPONSES TO ANALGESICS AND PLACEBO—STATISTICAL ANALYSIS

, 1957
H.H. Keasling, E Gross
openalex   +1 more source

Comparison of two doses of cimetidine and placebo in the treatment of duodenal ulcer: a multicentre trial. [PDF]

, 1979
Karna Dev Bardhan, Dominik Saul, Rotherham Hospital, John Edwards, Paul Smith, Llandough Hospital, M. R. Fettes, J. A. H. Forrest, R C Heading, Robert A. Logan, M W Dronfield, M J Langman, W Larkworthy, Nocton Hall, S J Haggie, J H Wyllie, Chris Corbett, H L Duthie, I Fussey, C.H. Holdsworth, G. V. Balmforth, Takashi Maruyama   +21 more
openalex   +1 more source

Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis

Annals of Neurology, EarlyView.
Objective A better understanding of factors associated with multiple sclerosis (MS) disease activity and disability is needed. Given the strong link between comorbid depression and MS disease activity and disability, we aimed to determine whether the depression genetic burden, as modelled using its polygenic score, is associated with MS disease ...
Ali Manouchehrinia, Kathryn C. Fitzgerald, Amber Salter, Ruth Ann Marrie, Lars Alfredsson, Charles N. Bernstein, James M. Bolton, Gary Cutter, John D. Fisk, Lesley A. Graff, Carol A. Hitchon, Jan Hillert, Ingrid Kockum, Yi Lu, Fred D. Lublin, Kyla McKay, Tomas Olsson, Scott Patten, Amit Patki, Hayley Riel, Klementy Shchetynsky, Pernilla Stridh, Hemant K. Tiwari, Jerry S. Wolinsky, Kaarina Kowalec   +24 more
wiley   +1 more source

12 Time to Sustained Recovery between Oral Tablet and Inhaler Placebos in the ACTIV-6 Platform Clinical Trial

Journal of Clinical and Translational Science
OBJECTIVES/GOALS: Platform trials gain efficiency by sharing placebo controls among different study arms. However, the varying routes of administration make it unclear whether participants exposed to different placebos have similar outcomes.
Yue Gao, Ahmad Mourad, Chris Lindsell, Thomas Stewart   +3 more
doaj   +1 more source

PLACEBO

, 1957

openalex   +1 more source

Methotrexate compared with placebo in lung cancer [PDF]

, 1977
Oleg S. Selawry, Melvin J. Krant, Joseph Scotto, Elias Kazam, Marvin A. Schneiderman, Kenneth B. Olson, Bruce I. Shnider, John H. Edmonson, Rth Ho, Samuel Taylor   +9 more
openalex   +1 more source